• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放血绵羊中促红细胞生成素刺激的网织红细胞反应的药效学分析。

A pharmacodynamic analysis of erythropoietin-stimulated reticulocyte response in phlebotomized sheep.

作者信息

Chapel S H, Veng-Pedersen P, Schmidt R L, Widness J A

机构信息

The Colleges of Pharmacy, Department of Pediatrics, The University of Iowa, Iowa City, USA.

出版信息

J Pharmacol Exp Ther. 2000 Oct;295(1):346-51.

PMID:10992000
Abstract

The pharmacodynamics (PD) of the reticulocyte response resulting from phlebotomy-induced erythropoietin (EPO) was investigated in adult sheep. The anemia caused by the controlled phlebotomy (Hb < 4 g/dl, t = 0) resulted in a rapid increase in EPO with peak concentrations from 200 to 1400 mU/ml at 0.5 to 3 days generating a delayed reticulocyte response with peak levels from 9.3 to 14.1% at 2.5 to 5.1 days. The PD EPO-reticulocyte relationship is well described by a simple kinetic model involving 3 relevant physiologic parameters: T(1) = lag-time (0.73 +/- 0.32 days, mean +/- S.D.), T(2) = reticulocyte maturation time (5.61 +/- 1.41 days), and k = EPO efficacy coefficient (0.052 +/- 0.048% g/dl mU/ml/day). Accordingly, 0.52% reticulocytes at 10 g/dl Hb level are generated per day at an EPO concentration of 100 mU/ml. The difference between the T(2) parameter in this study and the maturation time reported for humans may be due to interspecies differences or different technique and experimental conditions. The PD transduction appears largely linear in the observed EPO concentration range, indicating a full utilization of EPO without any significant PD saturation. Also, the EPO concentration versus time profiles resulting from the phlebotomy were similar to exogenous EPO profiles resulting from s.c. therapeutic dosing. This study supports the hypothesis that s.c. EPO dosing is more efficacious than i.v. dosing.

摘要

在成年绵羊中研究了放血诱导的促红细胞生成素(EPO)所引起的网织红细胞反应的药效学(PD)。控制性放血(Hb < 4 g/dl,t = 0)所导致的贫血使EPO迅速增加,在0.5至3天时峰值浓度为200至1400 mU/ml,产生延迟的网织红细胞反应,在2.5至5.1天时峰值水平为9.3%至14.1%。EPO-网织红细胞关系的PD可用一个涉及3个相关生理参数的简单动力学模型很好地描述:T(1)=延迟时间(0.73±0.32天,平均值±标准差),T(2)=网织红细胞成熟时间(5.61±1.41天),以及k = EPO效能系数(0.052±0.048% g/dl mU/ml/天)。因此,在EPO浓度为100 mU/ml时,每天在Hb水平为10 g/dl时产生0.52%的网织红细胞。本研究中T(2)参数与报道的人类成熟时间之间的差异可能是由于种间差异或不同的技术和实验条件。在观察到的EPO浓度范围内,PD转导在很大程度上呈线性,表明EPO得到充分利用,没有任何明显的PD饱和。此外,放血所导致的EPO浓度随时间变化曲线与皮下治疗给药所产生的外源性EPO曲线相似。本研究支持皮下注射EPO给药比静脉注射给药更有效的假说。

相似文献

1
A pharmacodynamic analysis of erythropoietin-stimulated reticulocyte response in phlebotomized sheep.放血绵羊中促红细胞生成素刺激的网织红细胞反应的药效学分析。
J Pharmacol Exp Ther. 2000 Oct;295(1):346-51.
2
Pharmacokinetic/pharmacodynamic analysis of paradoxal regulation of erythropoietin production in acute anemia.急性贫血中促红细胞生成素产生反常调节的药代动力学/药效学分析
J Pharmacol Exp Ther. 2004 Jul;310(1):202-8. doi: 10.1124/jpet.104.066027. Epub 2004 Feb 26.
3
Erythropoietin production rate in phlebotomy-induced acute anemia.放血诱导的急性贫血中促红细胞生成素的产生率
Biopharm Drug Dispos. 2004 Dec;25(9):389-97. doi: 10.1002/bdd.424.
4
An integrated pharmacodynamic analysis of erythropoietin, reticulocyte, and hemoglobin responses in acute anemia.急性贫血中促红细胞生成素、网织红细胞和血红蛋白反应的综合药效学分析
Pharm Res. 2002 Nov;19(11):1630-5. doi: 10.1023/a:1020797110836.
5
Pharmacodynamic analysis of changes in reticulocyte subtype distribution in phlebotomy-induced stress erythropoiesis.放血诱导应激性红细胞生成中网织红细胞亚型分布变化的药效学分析
J Pharmacokinet Pharmacodyn. 2005 Aug;32(3-4):359-76. doi: 10.1007/s10928-005-0009-3.
6
Pharmacodynamic analysis of time-variant cellular disposition: reticulocyte disposition changes in phlebotomized sheep.时变细胞处置的药效学分析:放血绵羊的网织红细胞处置变化
J Pharmacokinet Pharmacodyn. 2007 Aug;34(4):519-47. doi: 10.1007/s10928-007-9056-2. Epub 2007 May 22.
7
The effect of phlebotomy on serum erythropoietin levels in normal healthy subjects.放血疗法对正常健康受试者血清促红细胞生成素水平的影响。
Int J Hematol. 1992 Apr;55(2):111-5.
8
Receptor-based dosing optimization of erythropoietin in juvenile sheep after phlebotomy.放血后幼年绵羊基于受体的促红细胞生成素剂量优化。
Drug Metab Dispos. 2011 Jul;39(7):1214-20. doi: 10.1124/dmd.110.036855. Epub 2011 Apr 1.
9
Pharmacokinetic and pharmacodynamic studies following percutaneous absorption of erythropoietin micropiles to rats.促红细胞生成素微堆经皮吸收至大鼠后的药代动力学和药效学研究。
J Control Release. 2007 Aug 28;121(3):176-80. doi: 10.1016/j.jconrel.2007.05.028. Epub 2007 Jun 2.
10
Modeling time variant distributions of cellular lifespans: increases in circulating reticulocyte lifespans following double phlebotomies in sheep.细胞寿命的时变分布建模:绵羊重复放血后循环网织红细胞寿命的增加
J Pharmacokinet Pharmacodyn. 2008 Jun;35(3):285-323. doi: 10.1007/s10928-008-9089-1. Epub 2008 Jun 14.

引用本文的文献

1
A biomathematical model of human erythropoiesis under erythropoietin and chemotherapy administration.促红细胞生成素和化疗药物作用下的人类红细胞生成的生物数学模型。
PLoS One. 2013 Jun 6;8(6):e65630. doi: 10.1371/journal.pone.0065630. Print 2013.
2
Receptor-based dosing optimization of erythropoietin in juvenile sheep after phlebotomy.放血后幼年绵羊基于受体的促红细胞生成素剂量优化。
Drug Metab Dispos. 2011 Jul;39(7):1214-20. doi: 10.1124/dmd.110.036855. Epub 2011 Apr 1.
3
Pharmacokinetic analysis of continuous erythropoietin receptor activator disposition in adult sheep using a target-mediated, physiologic recirculation model and a tracer interaction methodology.
采用基于靶标的生理再循环模型和示踪剂相互作用方法分析成年绵羊中持续红细胞生成素受体激活剂的药代动力学。
Drug Metab Dispos. 2011 Apr;39(4):603-9. doi: 10.1124/dmd.110.036236. Epub 2011 Jan 5.
4
Interpretation of transit compartments pharmacodynamic models as lifespan based indirect response models.将转运室药效动力学模型解释为基于寿命的间接反应模型。
J Pharmacokinet Pharmacodyn. 2011 Apr;38(2):179-204. doi: 10.1007/s10928-010-9183-z. Epub 2010 Nov 24.
5
Pharmacokinetics and pharmacodynamics of the erythropoietin Mimetibody construct CNTO 528 in healthy subjects.促红细胞生成素模拟抗体构建体CNTO 528在健康受试者中的药代动力学和药效学
Clin Pharmacokinet. 2009;48(9):601-13. doi: 10.2165/11317190-000000000-00000.
6
Quantitative analysis of mechanisms that govern red blood cell age structure and dynamics during anaemia.贫血期间调控红细胞年龄结构和动态变化机制的定量分析
PLoS Comput Biol. 2009 Jun;5(6):e1000416. doi: 10.1371/journal.pcbi.1000416. Epub 2009 Jun 26.
7
Erythropoietin pharmacokinetic/pharmacodynamic analysis suggests higher doses in treating neonatal anemia.促红细胞生成素的药代动力学/药效学分析表明,治疗新生儿贫血时需要更高剂量。
Pediatr Int. 2009 Feb;51(1):25-32. doi: 10.1111/j.1442-200X.2008.02648.x.
8
Modeling time variant distributions of cellular lifespans: increases in circulating reticulocyte lifespans following double phlebotomies in sheep.细胞寿命的时变分布建模:绵羊重复放血后循环网织红细胞寿命的增加
J Pharmacokinet Pharmacodyn. 2008 Jun;35(3):285-323. doi: 10.1007/s10928-008-9089-1. Epub 2008 Jun 14.
9
Basic pharmacodynamic models for agents that alter the lifespan distribution of natural cells.改变天然细胞寿命分布的药物的基本药效学模型。
J Pharmacokinet Pharmacodyn. 2008 Jun;35(3):349-77. doi: 10.1007/s10928-008-9092-6. Epub 2008 Jun 13.
10
Pharmacodynamic model for chemotherapy-induced anemia in rats.大鼠化疗诱导贫血的药效学模型。
Cancer Chemother Pharmacol. 2008 Jun;62(1):123-33. doi: 10.1007/s00280-007-0582-9. Epub 2007 Sep 22.